Control of In Vivo Contraction/Relaxation Kinetics by Myosin Binding Protein C: Protein Kinase A Phosphorylation–Dependent and –Independent Regulation

Background— Cardiac myosin binding protein-C (cMyBP-C) is a thick-filament protein whose presence and phosphorylation by protein kinase A (PKA) regulates cross-bridge formation and kinetics in isolated myocardium. We tested the influence of cMyBP-C and its PKA-phosphorylation on contraction/relaxation kinetics in intact hearts and revealed its essential role in several classic properties of cardiac function. Methods and Results— Comprehensive in situ cardiac pressure–volume analysis was performed in mice harboring a truncation mutation of cMyBP-C (cMyBP-C(t/t)) that resulted in nondetectable protein versus hearts re-expressing solely wild-type (cMyBP-CWT:(t/t)) or mutated protein in which known PKA-phosphorylation sites were constitutively suppressed (cMyBP-CAllP-:(t/t)). Hearts lacking cMyBP-C had faster early systolic activation, which then terminated prematurely, limiting ejection. Systole remained short at faster heart rates; thus, cMyBP-C(t/t) hearts displayed minimal rate-dependent decline in diastolic time and cardiac preload. Furthermore, prolongation of pressure relaxation by afterload was markedly blunted in cMyBP-C(t/t) hearts. All 3 properties were similarly restored to normal in cMyBP-CWT:(t/t) and cMyBP-CAllP-:(t/t) hearts, which supports independence of PKA-phosphorylation. However, the dependence of peak rate of pressure rise on preload was specifically depressed in cMyBP-CAllP-:(t/t) hearts, whereas cMyBP-C(t/t) and cMyBP-CAllP-:(t/t) hearts had similar blunted adrenergic and rate-dependent contractile reserve, which supports linkage of these behaviors to PKA-cMyBP-C modification. Conclusions— cMyBP-C is essential for major properties of cardiac function, including sustaining systole during ejection, the heart-rate dependence of the diastolic time period, and relaxation delay from increased arterial afterload. These are independent of its phosphorylation by PKA, which more specifically modulates early pressure rise rate and adrenergic/heart rate reserve.

[1]  R. Moss,et al.  In vivo left ventricular functional capacity is compromised in cMyBP-C null mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[2]  D. Kass,et al.  Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload , and force-frequency responses and systolic function , 2006 .

[3]  H. Granzier,et al.  New insights in the role of cardiac myosin binding protein C as a regulator of cardiac contractility. , 2006, Circulation research.

[4]  R. Moss,et al.  Protein Kinase A–Mediated Acceleration of the Stretch Activation Response in Murine Skinned Myocardium Is Eliminated by Ablation of cMyBP-C , 2006, Circulation research.

[5]  R. Moss,et al.  Contributions of Stretch Activation to Length-dependent Contraction in Murine Myocardium , 2006, The Journal of general physiology.

[6]  R. Cole,et al.  Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts — Evidence for novel phosphorylation sites , 2006, Proteomics.

[7]  R. Moss,et al.  Ablation of myosin-binding protein-C accelerates force development in mouse myocardium. , 2006, Biophysical journal.

[8]  M. Gautel,et al.  Activation of Myocardial Contraction by the N-Terminal Domains of Myosin Binding Protein-C , 2006, Circulation research.

[9]  R. Moss,et al.  Ablation of Cardiac Myosin-Binding Protein-C Accelerates Stretch Activation in Murine Skinned Myocardium , 2006, Circulation research.

[10]  G. Vassort,et al.  Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. , 2006, Cardiovascular research.

[11]  K. Campbell,et al.  Functions of Stretch Activation in Heart Muscle , 2006, The Journal of general physiology.

[12]  L. Larsson,et al.  Activation Dependence of Stretch Activation in Mouse Skinned Myocardium: Implications for Ventricular Function , 2006, The Journal of general physiology.

[13]  J. Seidman,et al.  Cardiac Myosin-Binding Protein-C Phosphorylation and Cardiac Function , 2005, Circulation research.

[14]  Daniel C. Lee,et al.  Myosin-Binding Protein C Phosphorylation, Myofibril Structure, and Contractile Function During Low-Flow Ischemia , 2005, Circulation.

[15]  H. Watkins,et al.  Cardiac Myosin Binding Protein C: Its Role in Physiology and Disease , 2004, Circulation research.

[16]  D. Kass,et al.  Role of Cardiac Myosin Binding Protein C in Sustaining Left Ventricular Systolic Stiffening , 2004, Circulation research.

[17]  D. Kass,et al.  Frequency- and Afterload-Dependent Cardiac Modulation In Vivo by Troponin I With Constitutively Active Protein Kinase A Phosphorylation Sites , 2004, Circulation research.

[18]  T. Gillebert,et al.  Load Dependent Diastolic Dysfunction in Heart Failure , 2000, Heart Failure Reviews.

[19]  L. Carrier,et al.  Effect of MyBP-C Binding to Actin on Contractility in Heart Muscle , 2003, The Journal of general physiology.

[20]  K. McDonald,et al.  Loaded Shortening, Power Output, and Rate of Force Redevelopment Are Increased With Knockout of Cardiac Myosin Binding Protein-C , 2003, Circulation research.

[21]  J. Squire,et al.  Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain. , 2003, Journal of molecular biology.

[22]  D. Kass,et al.  Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.

[23]  H. Watkins,et al.  Identification of Novel Interactions Between Domains of Myosin Binding Protein-C That Are Modulated by Hypertrophic Cardiomyopathy Missense Mutations , 2002, Circulation research.

[24]  K. McDonald,et al.  Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice , 2002, Circulation research.

[25]  I. Kulikovskaya,et al.  Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C. , 2001, Biophysical journal.

[26]  I Kulikovskaya,et al.  Multiple structures of thick filaments in resting cardiac muscle and their influence on cross-bridge interactions. , 2001, Biophysical journal.

[27]  D. Kass,et al.  Minimal force‐frequency modulation of inotropy and relaxation of in situ murine heart , 2001, The Journal of physiology.

[28]  D. Uttenweiler,et al.  Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. , 2000, Circulation research.

[29]  D. Kass,et al.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. , 1999, The Journal of clinical investigation.

[30]  C. H. Chen,et al.  Comparison of ventricular pressure relaxation assessments in human heart failure: quantitative influence on load and drug sensitivity analysis. , 1999, Journal of the American College of Cardiology.

[31]  M. Gautel,et al.  Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. , 1999, Journal of molecular biology.

[32]  J. Dignam,et al.  Cardiac myosin-binding protein C (MyBP-C): identification of protein kinase A and protein kinase C phosphorylation sites. , 1998, Archives of biochemistry and biophysics.

[33]  H Niimura,et al.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.

[34]  T. Mikawa,et al.  The carboxyl terminus of myosin binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle. , 1996, Journal of cell science.

[35]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[36]  D. Kass,et al.  Diminished Contractile Response to Increased Heart Rate in Intact Human Left Ventricular Hypertrophy Systolic Versus Diastolic Determinants , 1993, Circulation.

[37]  W. Lew,et al.  Influence of systolic pressure profile on rate of left ventricular pressure fall. , 1991, The American journal of physiology.

[38]  G. Freeman,et al.  Comparison of effects of dobutamine and ouabain on left ventricular contraction and relaxation in closed-chest dogs. , 1987, The Journal of clinical investigation.

[39]  W. Little,et al.  The Left Ventricular dP/dtmax‐End‐Diastolic Volume Relation in Closed‐Chest Dogs , 1985, Circulation research.

[40]  G A Ahearn,et al.  Intestinal electrophysiology and transmural ion transport in freshwater prawns. , 1980, The American journal of physiology.

[41]  W. Gaasch,et al.  Myocardial relaxation. II. Hemodynamic determinants of rate of left ventricular isovolumic pressure decline. , 1980, The American journal of physiology.

[42]  Y. Henderson.  THE VOLUME CURVE OF THE VENTRICLES OF THE MAMMALIAN HEART, AND THE SIGNIFICANCE OF THIS CURVE IN RESPECT TO THE MECHANICS OF THE HEART-BEAT AND THE FILLING OF THE VENTRICLES , 1906 .

[43]  W. Porter.  Researches on the Filling of the Heart , 1892, The Journal of physiology.